Peer-influenced content. Sources you trust. No registration required. This is HCN.

OBR Oncology“Eye-Popping” Results From Adding Venetoclax to CLIA in Newly Diagnosed AML

Patients with newly diagnosed acute myeloid leukemia (AML) have had better results thanks to alterations to cytarabine/anthracycline-based intense chemotherapy, including the addition of high-dose cytarabine and adjustments to the dosage schedule or type of anthracycline.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form